Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nisa Maria"'
Autor:
Roshamur Cahyan Forestrania, Febrina Amelia Saputri, Kartika Citra Dewi Permata Sari, Nisa Maria, Taufiq Indra Rukmana, Hindun Wilda Risni, Donna Maretta Ariestanti, Berna Elya
Publikováno v:
Dinamisia, Vol 7, Iss 1, Pp 76-91 (2023)
The community service program in Sasak Panjang Village, Bogor Regency, started with an assessment of the problems and potency of the village. These problems are the lack of close access to health care services and the failure to cultivate Family Medi
Externí odkaz:
https://doaj.org/article/666fa3b381254ba18be824062887b79e
Publikováno v:
SAINSTECH FARMA. 15:1-8
Selama masa pandemi Coronavirus disease 2019 (COVID-19), apoteker harus tetap memberikan pelayanan farmasi klinik di apotek. Apoteker di apotek merupakan sumber informasi terkait penggunaan obat yang mudah diakses oleh masyarakat. Tetapi pelaksanaan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee287e228fb46fcb44a69d95161a956
https://doi.org/10.37277/sfj.v15i1.1091
https://doi.org/10.37277/sfj.v15i1.1091
Publikováno v:
Indonesian Journal of Clinical Pharmacy. 10:330-352
Opioid withdrawal syndrome appears after abrupt discontinuation of opioids characterized by watery eyes, runny nose, muscle pain, anxiety, yawning, gooseflesh, mydriasis, gastrointestinal discomfort, and rapid heartbeat. Globally, opioid abuse remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc87a648b3e5e98102478f3fb6b882e5
https://doi.org/10.15416/ijcp.2021.10.4.330
https://doi.org/10.15416/ijcp.2021.10.4.330
Publikováno v:
Jurnal Ilmiah Farmasi; Vol 17, No 2 (2021): Jurnal Ilmiah Farmasi; 182-197
Background: Treatment guidelines of COVID-19 are changing continuously by involving many off-label and various symptomatic or supportive drugs. The use of these various drugs might increase the patient’s risk of developing drug interactions.Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc8d0fd810238783642e6049b041b7a3
https://doi.org/10.20885/jif.vol17.iss2.art8
https://doi.org/10.20885/jif.vol17.iss2.art8
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. 10:194
Objective: This study aimed to evaluate the impact of antituberculosis (anti-TB) drug-induced hepatotoxicity (DIH) to outcome TB treatment.Methods: A cohort retrospective study conducted at a tertiary hospital in Jakarta - Indonesia, from the period
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27756d74dd6f58fa87564c5cec7022cb
https://doi.org/10.22159/ajpcr.2017.v10i11.20386
https://doi.org/10.22159/ajpcr.2017.v10i11.20386
Autor:
NISA, MARIA
Indonesia adalah negara dengan prevalensi tuberkulosis ketiga tertinggi di dunia (0,234% dari total populasi), sedangkan prevalensi tuberkulosis di Malaysia lebih sedikit (0,103% dari total populasi). Tujuan dari penelitian ini adalah mengetahui pola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4674::4e2d5bc3b0e57c1bfc066cd6150c2ef9
http://repo.unand.ac.id/2386/1/IMG.pdf
http://repo.unand.ac.id/2386/1/IMG.pdf
